Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Dexmedetomidine as an Adjuvant During Dural Puncture Epidural

NCT: NCT07506044 · RECRUITING

NCT IDNCT07506044
StatusRECRUITING
Start Date2026-02-01
Completion2026-08-30

Brief Summary

The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.

Frequently Asked Questions

What is Dexmedetomidine as an Adjuvant During Dural Puncture Epidural?

Dexmedetomidine as an Adjuvant During Dural Puncture Epidural is a clinical trial registered under NCT07506044. Current status: RECRUITING.

What is the status of NCT07506044?

The current status of NCT07506044 (Dexmedetomidine as an Adjuvant During Dural Puncture Epidural) is: RECRUITING.

When did Dexmedetomidine as an Adjuvant During Dural Puncture Epidural start?

Dexmedetomidine as an Adjuvant During Dural Puncture Epidural started on 2026-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑